SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|
| FOSIPRIL 10 mg tablet | 10 mg | Tablet · Oral use | 30 Blister | SAR 41.95 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Withdrawn by MAH · Not Marketed |
| FOSOPRIL 10 mg tablet | 10 mg | Tablet · Oral use | 30 Blister | SAR 37.75 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| FOSOPRIL 20 mg tablet | 20 mg | Tablet · Oral use | 30 Blister | SAR 66.00 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| FOSOPRIL 40 mg tablet | 40 mg | Tablet · Oral use | 30 Blister | SAR 132.00 | Generic · Prescription | RIYADH PHARMA | Withdrawn by MAH · Not Marketed |
| STARIL 10MG TAB | 10 mg | Tablet · Oral use | 30 Blister | SAR 51.65 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| STARIL 20MG TAB | 20 mg | Tablet · Oral use | 30 Blister | SAR 77.65 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | TEVA | Prescription | 25 Nov 2003 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | CHARTWELL RX | Prescription | 23 Apr 2004 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | INVAGEN PHARMS | Prescription | 20 Apr 2005 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 30 Mar 2011 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | PRINSTON INC | Prescription | 29 Aug 2016 |
| MONOPRIL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | BRISTOL MYERS SQUIBB | Discontinued | 16 May 1991 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | RANBAXY LABS LTD | Discontinued | 23 Apr 2004 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | UPSHER SMITH LABS | Discontinued | 8 Oct 2004 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | ACTAVIS LABS FL INC | Discontinued | 15 Oct 2004 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | WATSON LABS | Discontinued | 23 Dec 2004 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | APOTEX | Discontinued | 17 May 2005 |
| FOSINOPRIL SODIUM | 10MG; 20MG; 40MG | tablet · oral | WATSON LABS | Discontinued | 31 Aug 2006 |
Canada Canada — marketed products (Health Canada)
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|
| US NADAC | FOSINOPRIL SODIUM 10 MG TAB | $0.15419 | per EA | 23 Sep 2026 |
| US NADAC | FOSINOPRIL SODIUM 20 MG TAB | $0.1678 | per EA | 23 Sep 2026 |
| US NADAC | FOSINOPRIL SODIUM 40 MG TAB | $0.2119 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Fosinopril 10mg tablets | £5.11 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Fosinopril 20mg tablets | £2.93 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.